Pulmonary disease animal models are essential for replicating the pathological mechanisms of human lung diseases, facilitating the study of disease progression, evaluation of novel therapies, and assessment of drug efficacy.
These models are widely applied in research on chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, asthma, lung infections, and acute respiratory distress syndrome (ARDS).
SIDSCO Biomedical Co., Ltd., a subsidiary of Leadgene Biomedical, is a TAF-certified and GLP-compliant laboratory authorized to conduct toxicity testing for pharmaceuticals, health foods, and regenerative medicine products.
SIDSCO Biomedical develops pulmonary disease models using the following approaches:
|
